Reports Q1 revenue $321.3M, consensus $313.4M. “We had a good start to 2025, which positions us well to achieve our full-year guidance,” commented Patrick J. Beyer, CONMED’s (CNMD) President and Chief Executive Officer. “I am proud of our team’s dedication to strengthening our operations in order to better support our key growth platforms and drive long-term shareholder value.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNMD:
- CNMD Upcoming Earnings Report: What to Expect?
- Conmed downgraded to Hold from Buy at Stifel
- Andrew Moller Appointed as CONMED’s Principal Accounting Officer
- Tariff delay positive for Mexico-exposed medtech companies, says BofA